A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study, performed under the master protocol W8M-MC- CWMM (NCT06143956), is to evaluate the efficacy and safety of LY4086940 compared with placebo in participants without type 2 diabetes who have obesity or who have overweight with a weight-related health condition. Participation in the study will last about 58 weeks.
Epistemonikos ID: 2787a3ab6f854fdbc4df084e8db7fca4a1a5b816
First added on: Oct 23, 2026